Skip to content
10-Q

Quarterly Report

ACELYRIN, INC.

0001962918-24-000052

← back to feed
Filed
May 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 8, 2024 99.03M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $264.5M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $218.1M
Current Liabilities Q1 2024 · Mar 31, 2024 $52.28M
Current Liabilities Q1 2024 · Dec 31, 2023 $85.16M
Total Liabilities Q1 2024 · Mar 31, 2024 $53.42M
Total Liabilities Q1 2024 · Dec 31, 2023 $86.35M
Current Assets Q1 2024 · Mar 31, 2024 $693.98M
Current Assets Q1 2024 · Dec 31, 2023 $736.64M
Total Assets Q1 2024 · Mar 31, 2024 $697.48M
Total Assets Q1 2024 · Dec 31, 2023 $742.69M
Shares Diluted Q1 2024 · Mar 31, 2023 20.49M sh
Capex Q1 2024 · Mar 31, 2023 $238K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$25.33M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$143.35M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$102.86M
Eps Diluted Q1 2024 · Mar 31, 2023 −$8.61
Eps Basic Q1 2024 · Mar 31, 2023 −$8.61
Sga Expense Q1 2024 · Mar 31, 2023 $11.91M
Rd Expense Q1 2024 · Mar 31, 2023 $167.92M
Net Income Q1 2024 · Mar 31, 2023 −$176.45M
Operating Income Q1 2024 · Mar 31, 2023 −$179.83M